Angiodynamics (ANGO) Other financing activities (2010 - 2022)

Angiodynamics (ANGO) reported Other financing activities of $45000.0 for Q4 2022, down 93.63% quarter-over-quarter from $706000.0 in Q3 2022.

Angiodynamics (ANGO) Other financing activities (2010 - 2022) Analysis & Trends

Angiodynamics has reported Other financing activities for 9 years, with the latest figure at $45000.0 in Q4 2022.

For the quarter ending Q4 2022, Other financing activities changed N/A year-over-year to $45000.0; the trailing twelve-month figure through Aug 2023 stood at $45000.0 (down 93.63% YoY), and the FY2025 full-year result was $680000.0, changed N/A from the prior year.
Other financing activities for Q4 2022 stood at $45000.0, down from $706000.0 in the prior quarter.
The five-year high for Other financing activities was $741000.0 in Q3 2019, with the low at $34000.0 in Q1 2020.
Historically, Other financing activities has averaged $381500.0 across 3 years, with a median of $375500.0 in 2022.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Intuitive Surgical	148.09 Bn	143.69 Bn	1.83 Bn
2	Becton Dickinson	41.00 Bn	39.99 Bn	2.15 Bn
3	Medline	30.38 Bn	36.22 Bn	1.84 Bn
4	Resmed	28.22 Bn	26.56 Bn	890.98 Mn
5	West Pharmaceutical Services	23.72 Bn	23.19 Bn	296.40 Mn
6	Solventum	13.33 Bn	13.33 Bn	1.10 Bn
7	Cooper Companies	13.12 Bn	12.99 Bn	735.40 Mn
8	Align Technology	12.86 Bn	11.80 Bn	736.59 Mn
9	Baxter International	10.51 Bn	8.47 Bn	891.00 Mn
10	Angiodynamics	505.81 Mn	468.00 Mn	41.48 Mn

Download Data